| Apr-06-22 10:15AM |
10 Biotech Penny Stocks with Growth Catalysts |
Insider Monkey |
| Mar-28-22 03:00AM |
Pluristem and Tnuva to Ring Nasdaq Closing Bell in Honor of New Partnership |
GlobeNewswire |
| Mar-23-22 07:30AM |
Pluristem Releases PLX-R18 Hematology Phase I Study Results: Data Show Increase in All Blood Lines and Reduction in Blood Transfusions |
GlobeNewswire |
| Mar-08-22 07:12AM |
Pluristem and Tnuva Appoint Food Tech Veteran Eyal Rosenthal as Chief Executive Officer of their New Joint Venture |
GlobeNewswire |
| Mar-02-22 07:00AM |
Pluristem CEO Issues Shareholder Update |
GlobeNewswire |
| Feb-24-22 07:00AM |
Pluristem Announce the Closing of its Collaboration with Tnuva Group to Establish Cultured Food Platform |
GlobeNewswire |
| Jan-21-22 11:37AM |
15 Worst Stock Picks of Cathie Wood |
Insider Monkey |
| Jan-18-22 07:38AM |
Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday |
InvestorPlace |
| Jan-10-22 03:00AM |
Biotechnology Company Pluristem, and Israels Largest Food Producer Tnuva, Launch Landmark Collaboration to Establish Cultured Food Platform |
GlobeNewswire |
| Dec-28-21 12:04PM |
Pluristem (PSTI) Misses Study Goal to Treat COVID-Related ARDS |
Zacks |
| Dec-27-21 07:00AM |
Pluristem Reports Topline Results from its Phase II Studies of Acute Respiratory Distress Syndrome Associated with COVID-19 |
GlobeNewswire |
| Dec-27-21 06:31AM |
Pluristem Tanks as Covid Treatment Candidate Misses Endpoint in Study |
Investing.com |
| Nov-15-21 07:10AM |
Pluristem Completes Enrollment of Its Multinational Phase III Study of Muscle Regeneration Following Hip Fracture Surgery |
GlobeNewswire |
| Nov-10-21 07:00AM |
Pluristem Receives Approval for Grant from the Israel Innovation Authority to Develop its Next-Generation CRISPR PLX Platform |
GlobeNewswire |
| Sep-22-21 08:15AM |
Pluristem CEO Issues Shareholder Update |
GlobeNewswire |
| Sep-01-21 11:01AM |
Will Pluristem Therapeutics (NASDAQ:PSTI) Spend Its Cash Wisely? |
Simply Wall St. |
| Aug-24-21 11:32AM |
Cathie Wood is Getting Rid of These 10 Stocks |
Insider Monkey |
| Jul-19-21 07:00AM |
Pluristem Appoints Prof. Varda Shalev MD and Mr. Doron Birger to Join its Board of Directors |
GlobeNewswire |
| Jul-08-21 07:10AM |
Pluristem Brings ARDS Associated with COVID-19 Phase II Studies to Clinical Readout |
GlobeNewswire |
| Jun-21-21 08:04AM |
Mondays Pre-Market: Heres What You Need to Know Before the Market Opens |
TipRanks |
| Jun-21-21 04:36AM |
Deutsche Bank Jumps Back Into Payments With Fiserv Deal |
The Wall Street Journal |
| Jun-21-21 04:31AM |
Deutsche Bank and Fiserv Announce Joint Venture for Payment Acceptance in Germany |
Business Wire |
| May-25-21 08:48AM |
Pluristem Stock is Trading Higher After 20M Non-Dilutive Funding from European Investment Bank |
Benzinga |
| May-25-21 07:00AM |
Pluristem to Receive 20M Non-Dilutive Funding from the European Investment Bank |
GlobeNewswire |
| Apr-29-21 09:42AM |
Pluristem Stock Is Trading Higher As PLX-R18 Shows Regenerative Potential In Patients After Bone Marrow Transplant |
Benzinga |
| Apr-29-21 07:00AM |
Pluristem reports positive topline Phase I results in innovative hematology program, which is first to study PLX-R18 in humans |
GlobeNewswire |
| Apr-04-21 09:12PM |
Butterfly, Trimble, 10X Genomics, Pluristem, Agora What Cathy Wood's Ark Bought And Sold On Thursday |
Benzinga |
| Mar-05-21 02:52AM |
We're Keeping An Eye On Pluristem Therapeutics' (NASDAQ:PSTI) Cash Burn Rate |
Simply Wall St. |
| Feb-02-21 08:30AM |
Pluristem Therapeutics Inc. Announces $30 Million Registered Direct Offering |
GlobeNewswire |
| Jan-27-21 07:00AM |
Pluristem Announces Uplisting to the Nasdaq Global Market® |
GlobeNewswire |
| Jan-06-21 07:00AM |
Pluristem Announces Appointments of Two Directors to Board |
GlobeNewswire |
| Jan-04-21 02:52AM |
What You Need To Know About Pluristem Therapeutics Inc.'s (NASDAQ:PSTI) Investor Composition |
Simply Wall St. |
| Dec-29-20 07:00AM |
Pluristem Enters Collaboration With Pharmaceutical Company Innovare R&D to Expand Pluristems ARDS Associated With COVID-19 Program to Mexico |
GlobeNewswire |
| Dec-09-20 07:23AM |
The Daily Biotech Pulse: Roche & Moderna Strike COVID Testing Partnership, Rocket Pharma's Gene Therapy Readout, Breast Cancer Presentations |
Benzinga |
| Dec-09-20 04:00AM |
Pluristem Announces DMC Recommendation Following Interim Analysis of its Phase III CLI Study |
GlobeNewswire |
| Dec-02-20 03:52PM |
Where Do Hedge Funds Stand On Pluristem Therapeutics Inc. (PSTI)? |
Insider Monkey |
| Nov-18-20 07:00AM |
Pluristem to Present Initial Results from Its Phase I HCT Study with PLX-R18 Demonstrating Safety and Efficacy at the ASH Annual Meeting |
GlobeNewswire |
| Nov-03-20 10:57AM |
Pluristem Therapeutics Inc.'s (NASDAQ:PSTI) Path To Profitability |
Simply Wall St. |
| Oct-20-20 07:00AM |
World Experts in Infectious Diseases & Critical Care Form Pluristems COVID-19 Steering Committee |
GlobeNewswire |
| Oct-14-20 08:38AM |
Are Options Traders Betting on a Big Move in Pluristem Therapeutics (PSTI) Stock? |
Zacks |
| Oct-13-20 07:00AM |
Pluristem Announces Clearance to Move Forward with Enrollment for Cohort II in an Investigator-Led Phase I/II Chronic Graft vs Host Disease Study |
GlobeNewswire |
| Oct-07-20 07:30AM |
The Daily Biotech Pulse: Bristol-Myers Squibb's Lung Cancer Readout, Positive News From Masimo, Integra Lifesciences |
Benzinga |
| Oct-07-20 02:00AM |
Pluristem Expands its Phase II COVID-19 European Clinical Trial to Israel |
GlobeNewswire |
| Oct-01-20 03:00AM |
Abu Dhabi Stem Cells Center and Pluristem Unveil Joint Projects at Malta Conferences Foundation Online Event |
GlobeNewswire |
| Sep-15-20 07:30AM |
Pluristem CEO Issues Shareholder Update |
GlobeNewswire |
| Sep-14-20 03:15PM |
Companies Like Pluristem Therapeutics (NASDAQ:PSTI) Are In A Position To Invest In Growth |
Simply Wall St. |
| Aug-27-20 07:00AM |
Pluristem Launches FDA-Cleared COVID-19 Expanded Access Program, Enabling Patient Treatment Outside of Clinical Trial |
GlobeNewswire |
| Aug-20-20 09:46AM |
Pluristem Completes Enrollment in Phase I Hematology Study |
Zacks |
| Aug-19-20 07:00AM |
Pluristem Announces End of Patient Enrollment in its Phase I Hematology Study |
GlobeNewswire |
| Aug-17-20 09:09AM |
UAE and Israeli Companies Sign Deal on Stem Cell Research |
Bloomberg |
| Aug-17-20 02:00AM |
Pluristem and Abu Dhabi Stem Cells Center Sign MOU to Collaborate in the Development of Cell Therapies and Regenerative Medicines for the Treatment of Severe Diseases Including COVID-19 |
GlobeNewswire |
| Aug-10-20 08:44AM |
Pluristem Up 6% In Pre-Market On German Clearance For Covid-19 Study |
SmarterAnalyst |
| Aug-10-20 07:00AM |
Pluristem Expands its COVID-19 Program to Europe, Receives PEI Clearance to Commence Phase II Study in Germany |
GlobeNewswire |
| Jul-21-20 07:10AM |
Pluristem CEO Issues Shareholder Update on Clinical Programs |
GlobeNewswire |
| Jun-23-20 09:24PM |
Pluristem Is a High Risk, High Reward Play, Says Jefferies Analyst |
SmarterAnalyst |
| Jun-11-20 07:00AM |
Pluristem Announces Activation of Clinical Sites and Commencement of Patient Enrollment in U.S. FDA Phase II COVID-19 ARDS Trial |
GlobeNewswire |
| Jun-05-20 04:05PM |
Hedge Funds Nibbling On Pluristem Therapeutics Inc. (PSTI) |
Insider Monkey |
| Jun-03-20 07:00AM |
Pluristem Joins Forces with CRISPR-IL National Consortium to Advance Development of Cutting-Edge Genome Editing Solutions for Life Science Products |
GlobeNewswire |
| Jun-01-20 11:30AM |
Has Pluristem Therapeutics (PSTI) Outpaced Other Medical Stocks This Year? |
Zacks |
| May-15-20 11:30AM |
Is Pluristem Therapeutics (PSTI) Outperforming Other Medical Stocks This Year? |
Zacks |
| May-15-20 11:06AM |
Analyst Places a Long-Shot Bet on Pluristem (PSTI) Stock |
TipRanks |
| May-14-20 08:00AM |
Pluristem Provides 28-Day Follow Up for Ventilator-Dependent COVID-19 Patients under Compassionate Use Program in Israel and U.S. |
GlobeNewswire |
| May-08-20 07:59AM |
The Daily Biotech Pulse: Ayala IPO, Pluristem Starts Phase 2 Trial Of COVID Treatment, European Nod For Takeda |
Benzinga |
| May-08-20 06:00AM |
U.S. FDA Clears Pluristems IND Application for Phase II COVID-19 Study |
GlobeNewswire |
| May-05-20 09:56AM |
Pluristem Announces Pricing of Its Registered Direct Offering for Aggregate Proceeds of $15 Million |
GlobeNewswire |
| Apr-30-20 12:00PM |
Here's Why Momentum Investors Will Love Pluristem (PSTI) |
Zacks |
| Apr-30-20 09:30AM |
Pluristem Recaps Investor & Analyst Call Reviewing European Investment Banks 50 Million Financing |
GlobeNewswire |
| Apr-30-20 02:00AM |
EIB signs collaboration with Israel Innovation Authority and 50 million financing agreement with Pluristem to develop therapies for COVID-19 and other unmet medical needs |
GlobeNewswire |
| Apr-29-20 11:30AM |
Has Pluristem Therapeutics (PSTI) Outpaced Other Medical Stocks This Year? |
Zacks |
| Apr-28-20 06:40AM |
Are Stem Cells the COVID-19 Treatment We've All Been Waiting For? |
Motley Fool |
| Apr-27-20 06:00AM |
The European Investment Bank (EIB), EU Delegation to Israel, the Israel Innovation Authority, and Pluristem Cordially Invite the Public to an Online Signing Ceremony on April 30, 2020 |
GlobeNewswire |
| Apr-24-20 08:38AM |
The Daily Biotech Pulse: FDA Approves Sanofi's Meningococcal Vaccine, Pluristem Secures $54M In Funding For COVID-19 Treatment, Oric Pharma Prices IPO |
Benzinga |
| Apr-24-20 06:00AM |
Pluristem Secures 50 Million Non-Dilutive Financing from the European Investment Bank to Support its COVID-19 Project and Phase III Studies |
GlobeNewswire |
| Apr-23-20 03:05PM |
H.C. Wainwright Reiterates Upbeat View of Pluristem (PSTI) Following a Fireside Chat With CEO Yaky Yanay |
SmarterAnalyst |
| Apr-17-20 06:00AM |
Market Morning: Boeing Going On, Unemployment Confusion, Gilead Treatment, China Barely Contracts |
Market Exclusive |
| Apr-15-20 08:35AM |
The Zacks Analyst Blog Highlights: Pluristem Therapeutics, Mesoblast, Gilead Sciences, Pfizer and Regeneron |
Zacks |
| Apr-14-20 03:59PM |
Pluristem (PSTI): Strong Preliminary COVID-19 Results Are a Game Changer, Says Analyst |
TipRanks |
| Apr-14-20 09:53AM |
Pluristem Up on Cell Therapy Treatment of Coronavirus Patient |
Zacks |
| Apr-14-20 08:37AM |
Will Stem Cell Therapies Aid in Fight Against Coronavirus? |
Zacks |
| Apr-13-20 06:00AM |
Pluristem Expands its Compassionate Use Program: Treated First COVID-19 Patient in U.S. Under FDA Single Patient Expanded Access Program |
GlobeNewswire |
| Apr-10-20 11:38AM |
Pluristem Therapeutics Shares Jump on Covid-19 Study Results |
GuruFocus.com |
| Apr-09-20 08:32AM |
Implied Volatility Surging for Pluristem (PSTI) Stock Options |
Zacks |
| Apr-08-20 12:58PM |
Pluristem Changes the Game with Strong Preliminary COVID-19 Results; Analyst Says Buy |
TipRanks |
| Apr-07-20 07:50AM |
Pluristem Reports Preliminary Data from its COVID-19 Compassionate Use Program, Treating Seven Patients with Acute Respiratory Failure |
GlobeNewswire |
| Mar-30-20 07:30AM |
Pluristem Treated First Three COVID-19 Patients in Israel under Compassionate Use |
GlobeNewswire |
| Mar-26-20 08:00AM |
Pluristem Provides Update on COVID-19: Preparedness, Current Phase III Clinical Trials Status and Treatment Development Activity |
GlobeNewswire |
| Mar-21-20 10:31AM |
The Pluristem Therapeutics (NASDAQ:PSTI) Share Price Is Down 88% So Some Shareholders Are Rather Upset |
Simply Wall St. |
| Mar-17-20 08:47AM |
Israel to weigh "compassionate use" of Pluristem therapy for COVID-19 |
Reuters |
| Mar-17-20 08:30AM |
Israeli Ministry of Health Clears a Path to Allow Per Patient Compassionate Use Treatment of Covid-19 Patients with Pluristems PLX Cells |
GlobeNewswire |
| Mar-12-20 09:00AM |
Pluristem and Charité University of Medicine Berlin Join Forces Targeting Potential Treatment for Respiratory and Inflammatory Intratissue Complications Caused by COVID-19 |
GlobeNewswire |
| Mar-03-20 07:00AM |
Pluristem Receives Response from U.S. BARDA for Acute Radiation Syndrome Research Proposal |
GlobeNewswire |
| Feb-10-20 07:00AM |
Pluristem Therapeutics CEO Issues Shareholder Update |
GlobeNewswire |
| Feb-03-20 07:00AM |
In Its Path Towards Marketing, Pluristem Provides Highly Favorable Market Access Data Regarding the Critical Limb Ischemia Market in U.S. |
GlobeNewswire |
| Jan-09-20 11:53AM |
Does The Pluristem Therapeutics Inc. (NASDAQ:PSTI) Share Price Fall With The Market? |
Simply Wall St. |
| Dec-17-19 07:00AM |
Pluristem Completes 75% Enrollment in its Pivotal Phase III CLI Clinical Study |
GlobeNewswire |
| Dec-11-19 06:40AM |
Pluristem Therapeutics Shares March Higher, Can It Continue? |
Zacks |
| Dec-03-19 07:00AM |
Pluristem Reaches Milestone in its Phase III Muscle Injury Study, Completes 50% Enrollment |
GlobeNewswire |
| Nov-30-19 11:40AM |
Hedge Funds Have Never Been More Bullish On Pluristem Therapeutics Inc. (PSTI) |
Insider Monkey |
| Nov-19-19 11:06AM |
Pluristem Therapeutics (NASDAQ:PSTI) Will Have To Spend Its Cash Wisely |
Simply Wall St. |
| Nov-12-19 07:00AM |
Pluristem Therapeutics CEO Issues Shareholder Update |
GlobeNewswire |